Abbott India Ltd. News and Updates

Name: Latest research reports of Abbott India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Abbott India Ltd. from all sources in a single place.

Load latest

Abbott India Ltd.

15 May 2018, 12:00AM

31020.00

0.36%

Abbott India

Buy: Abbott India Ltd.

Target

ICICI Securities Limited

FY18 revenues increased 14% YoY to | 3299 crore mainly due to strong sales in power brands. Q4FY18 revenues grew 12% YoY EBITDA margins increased 221 bps to 15.9% YoY in FY18 mainly owing to robust gross margins. Gross margins improved 364 bps YoY to 73%. EBITDA margins in Q4FY18 increased to 83% from 67% in Q4FY17. EBITDA rose 32% YoY to | 525 crore in FY18 Net profit increased 45% YoY to | 401 crore in FY18. Q4FY18 net...

Abbott India Ltd. has an average target of 35626.00 from 3 brokers.

Abbott India Ltd.

02 Apr 2018

31020.00

0.36%

Corona Remedies acquires specific brand portfolio from Abbott India

Business Standard

Plan for substantially changing revenue mix over 3 years

Abbott India Ltd. is trading above its 200 day SMA of 30636.6

Corona Remedies acquires 2 brands from Abbott India

Business Line | 02 Apr 2018

Abbott India Ltd.

24 Mar 2018

31020.00

0.36%

Abbott India gets aggressive on new product launches, plans 110 in 5 years

Business Standard

The pharma firm, which had launched 14 products last year, is using social media to get into sub-therapies

Abbott India Ltd. is trading above its 200 day SMA of 30636.6

Abbott India Ltd.

21 Mar 2018

31020.00

0.36%

Abbott India gets aggressive on new product launches, plans 110 in 5 years

Business Standard

The pharma firm, which had launched 14 products last year, is using social media to get into sub-therapies

Abbott India Ltd. is trading above its 200 day SMA of 30636.6

Abbott India Ltd.

19 Dec 2017

31020.00

0.36%

Abbott India

Buy: Abbott India Ltd.

ICICI Securities Limited

Abbott India Ltd. is trading below its 30 day SMA of 32204.0

Abbott India Ltd.

22 Nov 2017

31020.00

0.36%

ABBOTT INDIA LTD

Buy: Abbott India Ltd.

Rudra Shares and Stock Brokers Ltd

Generic pharmaceuticals business has been trending well for Abbott Labs for some time now. It has a broad line of branded generic pharmaceuticals manufactured worldwide, and marketed and sold outside the U.S. The major products sold through this segment include Creon, Brufen, Biaxin, Influvac and Duphaston, among others. Looking forward, company expects double-digit...

Abbott India Ltd. is trading above its 200 day SMA of 30636.6

Abbott India Ltd.

13 Nov 2017

31020.00

0.36%

Abbott India Q2 profit rises 83% to Rs137.52 crore

livemint

Abbott India's total income rises to Rs946.04 crore for the September quarter

Abbott India Ltd. is trading below its 30 day SMA of 32204.0

Abbott India soars 20% on strong Q2 results

Business Standard | 13 Nov 2017

Abbott India Ltd.

08 Aug 2017

31020.00

0.36%

Abbott India Q1 net profit down 35% at Rs 48 cr

Business Line

Pharmaceuticals firm Abbott India today reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended June 30, with sales hit by de-stocking in trade channels ahead of...

Abbott India Ltd. is trading below its 30 day SMA of 32204.0

Abbott India Ltd.

26 Apr 2017

31020.00

0.36%

NPPA denies request for stent withdrawal by Abbott, India Medtronic

Business Line

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday denied the request for withdrawal of medical devices by Abbott Healthcare and India Medtronic. In an official statement, NPPA...

Abbott India Ltd. has an average target of 35626.00 from 3 brokers.

Abbott India Ltd.

21 Apr 2017

31020.00

0.36%

Price control fall out : Abbott withdraws two stents from Indian market

Business Line

A little over four years after Abbott introduced its bio-absorbable cardiac stent in India, the healthcare major has decided to pull the product out of India along with another stent Alpine....

Abbott India Ltd. is trading above its 200 day SMA of 30636.6

Is Abbott India Ltd. worth buying?

309 Votes:

Buy 79.29%

Sell 10.68%

Hold 10.03%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf